95 filings
Page 2 of 5
8-K
m5krqfpwt3mwplq01e
13 Jan 22
Unregistered Sales of Equity Securities
4:00pm
8-K
wacxrv
12 Nov 21
Eledon Pharmaceuticals Reports Third Quarter 2021 Operating and Financial Results
6:32am
8-K
itxlaw uurp25yjazrln
12 Aug 21
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
4:00pm
8-K
qxffk2ok
2 Aug 21
Departure of Directors or Certain Officers
9:00am
8-K
7hl1t2l nkcn554mb
2 Jul 21
Departure of Directors or Certain Officers
8:30am
8-K
pavsa4
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
ocyvzz6l295fg68w
13 May 21
Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results
4:22pm
8-K
lbmftzxsus twis76z
27 Apr 21
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
12:00am
8-K
jzi664k 4t
15 Mar 21
Departure of Directors or Certain Officers
2:00pm
8-K
k29f7f8uq
7 Jan 21
Unregistered Sales of Equity Securities
8:00am
8-K
hrmjq08p
5 Jan 21
Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
4:10pm
8-K
65hpdjn
22 Dec 20
Submission of Matters to a Vote of Security Holders
8:16am
8-K
ohtubwv622f zl
10 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
nc20zd
20 Nov 20
Amendments to Articles of Incorporation or Bylaws
4:18pm
8-K/A
iynkji
20 Nov 20
Financial Statements and Exhibits
8:32am
8-K
l47krl bipzyhi82j
6 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:45pm
8-K
x10ymaqa 1n002c
15 Sep 20
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
5:19pm
8-K
labn15h uqv
4 Sep 20
Departure of Directors or Certain Officers
4:25pm
8-K
eb63od5412al7t95i8
17 Jun 20
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
tghkwto6uvw d952
15 May 20
Novus Therapeutics Reports First Quarter 2020 Financial Results
6:32am